These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 15099314)

  • 1. Efficacy of sclerotherapy in varicose veins-- prospective, blinded, placebo-controlled study.
    Kahle B; Leng K
    Dermatol Surg; 2004 May; 30(5):723-8; discussion 728. PubMed ID: 15099314
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Sclerotherapy: a study comparing polidocanol in foam and liquid form.
    Uncu H
    Phlebology; 2010 Feb; 25(1):44-9. PubMed ID: 20118346
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Changes in venous function after foam sclerotherapy of varicose veins.
    Brunken A; Rabe E; Pannier F
    Phlebology; 2009 Aug; 24(4):145-50. PubMed ID: 19620696
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Multiple small-dose injections can reduce the passage of sclerosant foam into deep veins during foam sclerotherapy for varicose veins.
    Yamaki T; Nozaki M; Sakurai H; Takeuchi M; Soejima K; Kono T
    Eur J Vasc Endovasc Surg; 2009 Mar; 37(3):343-8. PubMed ID: 18922712
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Treatment of Truncal Incompetence and Varicose Veins with a Single Administration of a New Polidocanol Endovenous Microfoam Preparation Improves Symptoms and Appearance.
    King JT; O'Byrne M; Vasquez M; Wright D;
    Eur J Vasc Endovasc Surg; 2015 Dec; 50(6):784-93. PubMed ID: 26384639
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Efficacy and safety of great saphenous vein sclerotherapy using standardised polidocanol foam (ESAF): a randomised controlled multicentre clinical trial.
    Rabe E; Otto J; Schliephake D; Pannier F
    Eur J Vasc Endovasc Surg; 2008 Feb; 35(2):238-45. PubMed ID: 17988905
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Single-center experience with foam sclerotherapy without ultrasound guidance for treatment of varicose veins.
    Uurto I; Hannukainen J; Aarnio P
    Dermatol Surg; 2007 Nov; 33(11):1334-9; discussion 1339. PubMed ID: 17958585
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Sclerotherapy and foam sclerotherapy for varicose veins.
    Coleridge Smith P
    Phlebology; 2009 Dec; 24(6):260-9. PubMed ID: 19952382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment of varicose tributaries with sclerotherapy with polidocanol 0.5 % foam.
    Reich-Schupke S; Weyer K; Altmeyer P; Stücker M
    Vasa; 2010 May; 39(2):169-74. PubMed ID: 20464673
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Sclerotherapy of varicose veins with polidocanol based on the guidelines of the German Society of Phlebology.
    Rabe E; Pannier F
    Dermatol Surg; 2010 Jun; 36 Suppl 2():968-75. PubMed ID: 20590702
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [A case of rectal varices treated with endoscopic injection sclerotherapy].
    Zeniya A; Odashima M; Takahashi H; Ohkubo S; Masamune O
    Nihon Shokakibyo Gakkai Zasshi; 1997 Jan; 94(1):38-43. PubMed ID: 9028142
    [No Abstract]   [Full Text] [Related]  

  • 12. The VANISH-2 study: a randomized, blinded, multicenter study to evaluate the efficacy and safety of polidocanol endovenous microfoam 0.5% and 1.0% compared with placebo for the treatment of saphenofemoral junction incompetence.
    Todd KL; Wright DI;
    Phlebology; 2014 Oct; 29(9):608-18. PubMed ID: 23864535
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Polidocanol (Varithena) for varicose veins.
    Med Lett Drugs Ther; 2015 Aug; 57(1474):111-2. PubMed ID: 26218793
    [No Abstract]   [Full Text] [Related]  

  • 14. Efficacy and safety of Aethoxysklerol® (polidocanol) 0.5%, 1% and 3% in comparison with placebo solution for the treatment of varicose veins of the lower extremities in Chinese patients (ESA-China Study).
    Zhang J; Jing Z; Schliephake DE; Otto J; Malouf GM; Gu YQ
    Phlebology; 2012 Jun; 27(4):184-90. PubMed ID: 22045827
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparison of efficacy and safety between foam sclerotherapy and conventional sclerotherapy: a controlled clinical trial.
    Ukritmanoroat T
    J Med Assoc Thai; 2011 Mar; 94 Suppl 2():S35-40. PubMed ID: 21717876
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Outcomes of Foam Sclerotherapy plus Ligation versus Foam Sclerotherapy Alone for Venous Ulcers in Lower Extremities.
    Li X; Fan L; Ren S; Li X
    Ann Vasc Surg; 2017 Nov; 45():160-165. PubMed ID: 28648655
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Sclerotherapy of telangiectases and reticular veins: a double-blind, randomized, comparative clinical trial of polidocanol, sodium tetradecyl sulphate and isotonic saline (EASI study).
    Rabe E; Schliephake D; Otto J; Breu FX; Pannier F
    Phlebology; 2010 Jun; 25(3):124-31. PubMed ID: 20483861
    [TBL] [Abstract][Full Text] [Related]  

  • 18. One-shot scleroembolization: a new technique for the treatment of varicose veins disease of lower extremities. Preliminary results.
    Viani MP; Viani GM; Sergenti J
    Phlebology; 2014 Dec; 29(10):694-7. PubMed ID: 23934946
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Microfoam ultrasound-guided sclerotherapy treatment for varicose veins in a subgroup with diameters at the junction of 10 mm or greater compared with a subgroup of less than 10 mm.
    Barrett JM; Allen B; Ockelford A; Goldman MP
    Dermatol Surg; 2004 Nov; 30(11):1386-90. PubMed ID: 15522019
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Ultrasound-guided foam sclerotherapy for the treatment of varicose veins.
    Darke SG; Baker SJ
    Br J Surg; 2006 Aug; 93(8):969-74. PubMed ID: 16739097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.